Brief: Miromatrix Receives New Patent
25/08/2022 12:35
Aug 25 (Reuters) - Miromatrix Medical Inc MIRO.O :
* MIROMATRIX RECEIVES NEW PATENT FOR ITS NOVEL PERFUSION
DECELLULARIZATION AND RECELLULARIZATION TECHNOLOGY
Source text for Eikon: ID:nGNX12G8Nf
Further company coverage: MIRO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Miromatrix Medical
See all newsU.S. STOCKS ON THE MOVE-SeaStar, SJW Group, Pinterest
U.S. STOCKS ON THE MOVE-Crypto, Miromatrix Medical, US banks
U.S. STOCKS ON THE MOVE-JinkoSolar, Reviva, MeiraGTx
U.S. STOCKS ON THE MOVE-McDonald, Coherus BioSciences, Miromatrix,
Brief: Miromatrix To Pay United Therapeutics Termination Fee Of $4 Million In Connection With Termination Of Merger